{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:40:47Z","timestamp":1778514047644,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ijbiomac.2019.08.168","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T01:58:59Z","timestamp":1566266339000},"page":"1147-1157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["In vitro and in silico analysis of novel astaxanthin-s-allyl cysteine as an inhibitor of butyrylcholinesterase and various globular forms of acetylcholinesterases"],"prefix":"10.1016","volume":"140","author":[{"given":"Penislusshiyan","family":"Sakayanathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitra","family":"Loganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saravanan","family":"Kandasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh V.","family":"Ramanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumaradhas","family":"Poomani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Palvannan","family":"Thayumanavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/er.2007-0034","article-title":"Cognitive dysfunction and diabetes mellitus","volume":"29","author":"Kodl","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0010","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.neuron.2016.09.006","article-title":"Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline","volume":"91","author":"Ballinger","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0301-0082(93)90040-Y","article-title":"Molecular and cellular biology of cholinesterases","volume":"41","author":"Massouli\u00e9","year":"1993","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev.pa.34.040194.001433","article-title":"The cholinesterases: from genes to proteins","volume":"34","author":"Taylor","year":"1994","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/nbdi.2001.0462","article-title":"Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain","volume":"9","author":"Mesulam","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.lfs.2008.05.013","article-title":"Lycopene attenuates diabetes-associated cognitive decline in rats","volume":"83","author":"Kuhad","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2009.03.032","article-title":"Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats","volume":"610","author":"Schmatz","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbr.2011.01.022","article-title":"Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes","volume":"220","author":"Bhutada","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0045","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","article-title":"Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus","volume":"13","author":"Mushtaq","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.peptides.2016.10.008","article-title":"Carnosine ameliorates cognitive deficits in streptozotocin-induced diabetic rats: possible involved mechanisms","volume":"86","author":"Ahshin-Majd","year":"2016","journal-title":"Peptides"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2016.04.026","article-title":"N-acetylcysteine protects memory decline induced by streptozotocin in mice","volume":"253","author":"Costa","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11011-015-9779-5","article-title":"Puerarin ameliorates cognitive deficits in streptozotocin-induced diabetic rats","volume":"31","author":"Liu","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0065","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2337\/db07-0171","article-title":"Alzheimer-like changes in rat models of spontaneous diabetes","volume":"56","author":"Li","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0070","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuroscience.2008.03.019","article-title":"Increased amyloid beta-peptide (1-40) level in brain of streptozotocin-induced diabetic rats","volume":"153","author":"Liu","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jep.2011.11.004","article-title":"Total saponins from Rhizoma Anemarrhenae ameliorate diabetes-associated cognitive decline in rats: involvement of amyloid-beta decrease in brain","volume":"139","author":"Liu","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0080","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Honolulu-Asia Aging S. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0085","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF00334445","article-title":"Colocalization of cholinesterases with \u03b2 amy\nloid protein in aged and Alzheimer's brains","volume":"85","author":"Moran","year":"1993","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0304-3940(94)12127-C","article-title":"Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-beta-peptides","volume":"201","author":"Alvarez","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0095","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1523\/JNEUROSCI.18-09-03213.1998","article-title":"Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils","volume":"18","author":"Alvarez","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0100","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer \u03b2-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1326-5-4","article-title":"Amyloid-\u03b2-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the A\u03b2 peptide. Implications for the pathogenesis of Alzheimer's disease","volume":"5","author":"Dinamarca","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0110","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","article-title":"Butyrylcholinesterase-knockout reduces brain deposition of fibrillar beta-amyloid in an Alzheimer mouse model","volume":"298","author":"Reid","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0115","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2174\/1567205013666160404120542","article-title":"Butyrylcholinesterase as a diagnostic and therapeutic target for Alzheimer's disease","volume":"13","author":"Darvesh","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0120","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3233\/JAD-170164","article-title":"Quantification of butyrylcholinesterase activity as a sensitive and specific biomarker of Alzheimer's disease","volume":"58","author":"Macdonald","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1042\/cs0850077","article-title":"Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus","volume":"85","author":"Abbott","year":"1993","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0130","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.clinbiochem.2005.04.008","article-title":"Relationship between serum butyrylcholinesterase and the metabolic syndrome","volume":"38","author":"Randell","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0135","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2169\/internalmedicine.46.0049","article-title":"Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance","volume":"46","author":"Iwasaki","year":"2007","journal-title":"Intern. Med."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0140","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3892\/mmr.2015.4615","article-title":"Astaxanthin reduces type 2 diabetic-associated cognitive decline in rats via activation of PI3K\/Akt and attenuation of oxidative stress","volume":"13","author":"Li","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/md14040067","article-title":"Fucoxanthin, a marine carotenoid, reverses scopolamine-induced cognitive impairments in mice and inhibits acetylcholinesterase in vitro","volume":"14","author":"Lin","year":"2016","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijbiomac.2018.06.027","article-title":"Biological interaction of newly synthesized astaxanthin-s-allyl cysteine biconjugate with Saccharomyces cerevisiae and mammalian \u03b1-glucosidase: in vitro kinetics and in silico docking analysis","volume":"118","author":"Penislusshiyan","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0155","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0197-0186(92)90189-X","article-title":"Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development\u2014a study of molecular forms","volume":"21","author":"Arendt","year":"1992","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0160","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1046\/j.1471-4159.1999.721600.x","article-title":"Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease","volume":"72","author":"Saez-Valero","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008701","article-title":"Altered levels of acetylcholinesterase in Alzheimer plasma","volume":"5","author":"Garcia-Ayllon","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuint.2014.12.009","article-title":"Butyrylcholinesterase: K variant, plasma activity, molecular forms and rivastigmine treatment in Alzheimer's disease in a Southern Brazilian population","volume":"81","author":"Bono","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0175","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/prot.24267","article-title":"Interaction of metal chelators with different molecular forms of acetylcholinesterase and its significance in Alzheimer's disease treatment","volume":"81","author":"Chitra","year":"2013","journal-title":"Proteins"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0180","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1016\/S0021-9258(18)91063-X","article-title":"Structure of human erythrocyte acetylcholinesterase. Characterization of intersubunit disulfide bonding and detergent interaction","volume":"259","author":"Rosenberry","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0006-291X(74)80182-8","article-title":"The molecular weight and subunit structure of acetylcholinesterase preparations from the electric organ of the electric eel","volume":"59","author":"Dudai","year":"1974","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/370705","article-title":"Acetylcholinesterase from human erythrocytes as a surrogate biomarker of lead induced neurotoxicity","volume":"2015","author":"Gupta","year":"2015","journal-title":"Enzym. Res."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0195","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0200","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0205","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1042\/bj0550170","article-title":"The determination of enzyme inhibitor constants","volume":"55","author":"Dixon","year":"1953","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0210","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0215","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0220","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1261\/rna.1563609","article-title":"DOCK 6: combining techniques to model RNA\u2013small molecule complexes","volume":"15","author":"Lang","year":"2009","journal-title":"Rna"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0225","series-title":"AMBER 14","author":"Case","year":"2014"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0230","article-title":"New acetylcholinesterase inhibitors for Alzheimer's disease","volume":"2012","author":"Mehta","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0235","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00702-009-0189-x","article-title":"Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis","volume":"116","author":"B-s","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0240","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1016\/j.ijbiomac.2018.09.014","article-title":"Cholinesterases inhibition studies of biological active compounds from the rhizomes of Alpinia officinarum Hance and in silico molecular dynamics","volume":"120","author":"Lee","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0245","doi-asserted-by":"crossref","unstructured":"Li F-j, Liu Y, Yuan Y, Yang B, Liu Z-m, & Huang L-q (2017). Molecular interaction studies of acetylcholinesterase with potential acetylcholinesterase inhibitors from the root of Rhodiola crenulata using molecular docking and isothermal titration calorimetry methods. Int. J. Biol. Macromol. 104: 527\u2013532.","DOI":"10.1016\/j.ijbiomac.2017.06.066"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0250","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijbiomac.2019.05.132","article-title":"Effect of Salvia miltiorrhiza on acetylcholinesterase: enzyme kinetics and interaction mechanism merging with molecular docking analysis","volume":"135","author":"Tang","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijbiomac.2016.11.062","article-title":"Combining in silico and in vitro approaches to evaluate the acetylcholinesterase inhibitory profile of some commercially available flavonoids in the management of Alzheimer's disease","volume":"95","author":"Kuppusamy","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0260","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ijbiomac.2018.07.144","article-title":"Study of the interactions of forsythiaside and rutin with acetylcholinesterase (AChE)","volume":"119","author":"Yan","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0265","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1039\/C9NP00010K","article-title":"Natural cholinesterase inhibitors from marine organisms","volume":"36","author":"Moodie","year":"2019","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0270","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuint.2019.01.010","article-title":"In vitro studies of the neuroprotective activities of astaxanthin and fucoxanthin against amyloid beta (A\u03b21-42) toxicity and aggregation","volume":"124","author":"Alghazwi","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0275","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.biopha.2018.11.043","article-title":"Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by A\u03b2 peptides in animal model of Alzheimer's disease","volume":"110","author":"Rahman","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0280","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.mehy.2007.03.032","article-title":"Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease","volume":"69","author":"Rao","year":"2007","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0290","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-\u03b2-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0295","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1006\/bbrc.1997.6357","article-title":"A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme","volume":"232","author":"Reyes","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2019.08.168_bb0300","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-2952(02)01514-9","article-title":"\u03b2-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies","volume":"65","author":"Bartolini","year":"2003","journal-title":"Biochem. Pharmacol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813019350263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813019350263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:50:33Z","timestamp":1758873033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813019350263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":59,"alternative-id":["S0141813019350263"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.08.168","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in silico analysis of novel astaxanthin-s-allyl cysteine as an inhibitor of butyrylcholinesterase and various globular forms of acetylcholinesterases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.08.168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}